3 ms·
There ought be a bot to keep replying to people saying that the high margins in the US fund healthcare innovations. This is a popular narrative promoted by th
by willvarfar 5y ago
There ought be a bot to keep replying to people saying that the high margins in the US fund healthcare innovations.
This is a popular narrative promoted by the US medical industry. However, it doesn’t stand up to scrutiny. Just the first debunking I find in a google search is https://www.mhaonline.com/blog/healthcare-debates-funding-medical-research https://www.mhaonline.com/blog/healthcare-debates-funding-me...
I think the big profits to be made on _treating_ diereses in the US is probably a perverse incentive preventing those companies from developing preventative measures.
- kaczordon 5y agoThe article you linked disproves your point: In 2016, the US was responsible for 57 percent of new chemical entities worldwide. From this perspective, ensuring increased investment in R&D seems logical.